Improvement of the chromatographic separation of several 1,4-dihydropyridines calcium channel antagonist drugs by experimental design

Journal of Chromatographic Science

Volumn 43, Issue 10, 2005, Pages 505-512

  Baranda, Ana B ^a   Etxebarria, Nestor ^a   Jiménez, Rosa M ^a   Alonso, Rosa M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29144481696     PISSN: 00219665     EISSN: 00219665     Source Type: Journal    
DOI: 10.1093/chromsci/43.10.505     Document Type: Article

References (38)

1. W. Martindale. Martindale The Extra Paharmacopeia, J.E.F. Reynolds, Ed. Pharmaceutical Press, London, U.K., 1996.
2. W.G. Nayler. Calcium Antagonists. Academic Press, San Diego, CA, 1988.
3. J.R. Prous, Ed. Medicamentos de Actualidad (Drugs of Today). J.R. Prous, Barcelona, Spain, 1994, pp. 108-19.
4. W.G. Nayler. Calcium antagonists: past, present and future-a personal view. J. Clin. Basic Cardiol. 2: 155-61 (1999).
5. S.H. Zbigniew. Application of calcium channel blockers in the treatment of cardiovascular diseases. Pol. J. Pharmacol. 51: 201 (1999).
6. D.F. Cummins. Newer calcium channel antagonists and the treatment of hypertension. Exp. Opin. Invest. Drugs 8: 1031-42 (1999).
7. P.A. van Zwieten. The pharmacological properties of lipophilic calcium antagonists. Blood Pressure 7: S5-9 (1998).
8. K.P.R. Chowdory, K.G. Kumar, and G. Drao. Spectrometric determination of nitrendipine in pharmaceutical dosage forms. The Estern Pharmacist Jan: 139 (1999).
9. S.N. Meyynathan, M.T. Tonio, G.V.S. Rama Sarma, and B. Suresh. Spectrometric analysis of lacidipine in its dosage forms. The Estern Pharmacist July: 117 (1999).
10. S.A. Ozkan. Determination of the antihypertensive drug lacidipine in pharmaceuticals by differential pulse and square wave voltammetry. Pharmazie 57: 503-505 (2002).
11. A. Alvarez-Lueje, S. Pujol, L.J. Núñez-Vergara, and J.A. Squella. Differential pulse voltammetric assay of lercanidipine in tablets. J. AOAC Int. 85: 1247-52 (2002).
12. F. Belal, A. Al-Majed, and S. Julkhuf. Voltammetric determination of isradipine in dosage forms and spiked human plasma and urine. J. Pharm. Biomed. Anal. 31: 989-98 (2003).
13. M.M. Ghoneim, A. Tawfik, and P.Y. Khashaba. Cathodic adsorptive stripping square-wave voltammetric determination of nifedipine drug in bulk, pharmaceutical formulation and human serum. Anal. Bioanal. Chem . 375: 369 (2003).
14. A. Alvarez-Lueje, S. Pujol, J.A. Squella, and L.J. Núñez- Vergara. A selective HPLC method for determination of lercanidipine in tablets. J. Pharm. Biomed. Anal. 3: 1-9 (2003).
15. C.S. Eskilsson, E. Björklund, L. Mathiasson, L. Karlsson, and A. Torstensson. Microwave-assisted extraction of felodipine tablets. J. Chromatogr. A 840: 59-70 (1999).
16. Y.P. Patel, S. Patil, I.C. Bhoir, and M. Sundaresan. Isocratic simultaneous reversed-phase high-performance liquid chromatographic determination of six drugs for combined hypertension therapy. J. Chromatogr. A 828: 283-86 (1998).
17. A.B. Baranda, R.M. Jiménez, and R.M. Alonso. Simultaneous determination of five 1,4-dihydropyridines in pharmaceutical formulations by high-performance liquid chromatography-amperometric detection. J. Chromatogr. A 1031: 275-80 (2004).
18. A.B. Baranda, O. Berasaluce, R.M. Jiménez, and R.M. Alonso. Application of the experimental design to the development of a high performance liquid cromatography-diode array detection method for the analysis of several calcium channel blocking drugs. Chromatographia 61: 447-53 (2005).
19. C. Jean and R. Laplanche. Assay of isradipine and of its major metabolites in biological fluids by capillary gas chromatography and chemical ionization mass spectrometry. J. Chromatogr. 428: 61-69 (1988).
20. M.T. Rosseel and R.A. Lefebvre. Capillary gas chromatographic determination with nitrogen-phosphorus detection of the calcium antagonist nicardipine and its pyridine metabolite M-5 in plasma. J. Chromatogr. A 668: 475-80 (1994).
21. F. Scharpf, K.D. Riedel, H. Laufen, and M. Leitold. Enantioselective gas chromatographic assay with electron-capture detection for amlodipine in biological samples. J. Chromatogr. B Biomed. Appl. 655: 225-33 (1994).
22. R. Heinig, V. Muschalek, and G. Ahr. Determination of the enantiomers of nisoldipine in human plasma using high-performance liquid chromatography on a chiral stationary phase and gas chromatography with mass-selective detection. J. Chromatogr. B 655: 286-92 (1994).
23. M. Pawula, D. Watson, T. Teramura, T. Watanabe, S. Higuchi, and K.N. Cheng. Sensitive and specific liquid chromatographic-tandem mass spectrometric assay for barnidipine in human plasma. J. Chromatogr. B 719: 113-23 (1998).
24. W. Mück. Enantiospecific determination of nimodipine in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 712: 45-53 (1995).
25. D. Marszalek, A. Goldnik, R. Dabrowski, and M. Gajewska. Determination of Nitrendipine in serum and saliva by HPLC. Chem. Anal (Warsaw) 4: 705-709 (1999).
26. M. Josefsson, A.L. Zackrisson, and B. Norlander. Sensitive high-performance liquid chromatographic analysis of amlodipine in human plasma with amperometric detection and a single-step solid-phase sample preparation. J. Chromatogr. B 672: 310-13 (1995).
27. H.S. Abou-Auda, T.A. Najjar, K.I. Al-Khamis, B.M. Al-Hadiya, N.M. Ghilzai, and N.F. Al-Fawzan. Liquid chromatographic assay of nifedipine in human plasma and its application to pharmacokinetic studies. J. Pharm. Biom. Anal. 22: 241-49 (2000).
28. K. Esbensen, T. Midtgaard, and S. Schonkopf. Multivariate Analysis in Practice. CAMO ASA, Trondheim, Norway, 1994.
29. E. Morgan. Chemometrics-Experimental Design . John Wiley & Sons, Chichester, U.K., 1991.
30. M. Petz and M. Preu. Development and optimisation of a new derivatisation procedure for gas chromatographic-mass spectrometric analysis of dihydrostreptomycin: comparison of multivariate and step-by-step optimisation procedures. J. Chromatogr. A 840: 81-91 (1999).
31. J. Goupy. Methods for Experimental Design, Principles and Applications for Physicists and Chemists. Elsevier, Amsterdam, the Netherlands, 1992.
32. A.B. Baranda and W. Weinmann. Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples. Forensic Sci. Int., in press.
33. Consejo General de Colegios Oficiales Farmaceúticos (2002). Catálogo de Especialidades Farmaceúticas 2002. Consejo General de Colegios Oficiales Farmacéuticos, Madrid, Spain, 2002, pp.146-48.
34. M. Barchielli, E. Dolfini, P. Farina, B. Leoni, G. Targa, V. Vinaccia, and A. Tajana. Clinical pharmacokinetics of lercanidipine. J. Caridiovasc. Pharmacol. 29(suppl. 2): S1-15 (1997).
35. P.H. Sherrod. NLREG-nonlinear regression analysis program. NLREG, Nashville, TN, 1995.
36. Multisimplex 98. Bergström and Öberg, Karlskroma, Sweden, 1998.
37. A.B Baranda, N. Etxebarria, R.M. Alonso, and R.M. Jimenez. Development of a liquid-liquid extraction procedure for five 1,4-dihydropyridine calcium channel antagonists from human plasma. Talanta 67(5): 933-41 (2005).
38. A.B. Baranda and W. Weinmann. Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry. Therapeutic Drug Monit. 27(1): 44-52 (2005). Manuscript received April 11, 2004; revision received July 8, 2005.